Toward Illness Phase-Specific Pharmacotherapy for Schizophrenia

Biological Psychiatry

Volumn 78, Issue 11, 2015, Pages 738-740

  Krystal, John H ^a,b   Anticevic, Alan ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

^c Yale University School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; NEUROLEPTIC AGENT; POMAGLUMETAD METHIONIL; FUSED HETEROCYCLIC RINGS; METABOTROPIC RECEPTOR; SULFOXIDE;

CHRONIC DISEASE; COGNITIVE DEFECT; FUNCTIONAL DISEASE; HUMAN; NOTE; PRIORITY JOURNAL; SCHIZOPHRENIA; AGONISTS; FEMALE; MALE;

ANTIPSYCHOTIC AGENTS; BICYCLO COMPOUNDS, HETEROCYCLIC; CYCLIC S-OXIDES; FEMALE; HUMANS; MALE; RECEPTORS, METABOTROPIC GLUTAMATE; SCHIZOPHRENIA;

EID: 84960908805     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2015.08.017     Document Type: Note

References (10)

1. W.G. Frankle, R. Gil, E. Hackett, O. Mawlawi, Y. Zea-Ponce, Z. Zhu, and et al. Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: Theoretical implications Psychopharmacology (Berl) 175 2004 473 480
2. B.J. Kinon, B.A. Millen, L. Zhang, and D.L. McKinzie Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2/3 receptor agonist pomaglumetad methionil in schizophrenia Biol Psychiatry 78 2015 754 762
3. T.R. Insel Rethinking schizophrenia Nature 468 2010 187 193
4. Schizophrenia Working Group of the Psychiatric Genomics Consortium Biological insights from 108 schizophrenia-associated genetic loci Nature 511 2014 421 427
5. S. Kimoto, M.M. Zaki, H.H. Bazmi, and D.A. Lewis Altered markers of cortical gamma-aminobutyric acid neuronal activity in schizophrenia: Role of the NARP gene JAMA Psychiatry 72 2015 747 756
6. P.R. Huttenlocher Synaptic density in human frontal cortex - developmental changes and effects of aging Brain Res 163 1979 195 205
7. C. de la Fuente-Sandoval, P. Leon-Ortiz, R. Favila, S. Stephano, D. Mamo, J. Ramirez-Bermudez, and et al. Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis Neuropsychopharmacology 36 2011 1781 1791
8. J.D. Murray, A. Anticevic, M. Gancsos, M. Ichinose, P.R. Corlett, J.H. Krystal, and et al. Linking microcircuit dysfunction to cognitive impairment: Effects of disinhibition associated with schizophrenia in a cortical working memory model Cereb Cortex 24 2014 859 872
9. S.A. Schobel, N.H. Chaudhury, U.A. Khan, B. Paniagua, M.A. Styner, I. Asllani, and et al. Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver Neuron 78 2013 81 93
10. A. Anticevic, P.R. Corlett, M.W. Cole, A. Savic, M. Gancsos, Y. Tang, and et al. N-methyl-D-aspartate receptor antagonist effects on prefrontal cortical connectivity better model early than chronic schizophrenia Biol Psychiatry 77 2015 569 580